Chemomab Therapeutics Ltd
NASDAQ:CMMB
Chemomab Therapeutics Ltd
Tax Provision
Chemomab Therapeutics Ltd
Tax Provision Peer Comparison
Competitive Tax Provision Analysis
Latest Figures & CAGR of Competitors
Company | Tax Provision | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Chemomab Therapeutics Ltd
NASDAQ:CMMB
|
Tax Provision
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Collplant Biotechnologies Ltd
NASDAQ:CLGN
|
Tax Provision
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Kamada Ltd
NASDAQ:KMDA
|
Tax Provision
-$145k
|
CAGR 3-Years
53%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-22%
|
|
Urogen Pharma Ltd
NASDAQ:URGN
|
Tax Provision
-$3.9m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-98%
|
CAGR 10-Years
N/A
|
|
Entera Bio Ltd
NASDAQ:ENTX
|
Tax Provision
-$29k
|
CAGR 3-Years
-13%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
B
|
Bonus Biogroup Ltd
TASE:BONS
|
Tax Provision
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Chemomab Therapeutics Ltd's Tax Provision?
Tax Provision
0
USD
Based on the financial report for Dec 31, 2023, Chemomab Therapeutics Ltd's Tax Provision amounts to 0 USD.